Aspen Pharmacare signs voluntary licensing deal with MSD for once-monthly HIV prevention pill MK-8527PUBT·4 hours agoMRK+0.56%
First Trust Advisors LP Acquires 1,305 Shares of Eli Lilly and Company $LLYMarket Beat·9 hours agoLLY+1.31%ELIL+2.79%
Cardiovascular disease biotech Scribe Therapeutics prices upsized IPO at $15, the high end of the rangeRenaissanceCapital·4 hours agoSNY+8.00%LLY+1.31%
Genmab, AbbVie clarify primary endpoints in Phase 3 EPCORE DLBCL-1 trialPUBT·21 hours agoGMAB-1.20%ABBV+0.83%
Eli Lilly's Retatrutide Meets Primary Endpoint In Phase 3 TRIUMPH-2 And TRIUMPH-3 Trialsrttnews·1 day ago, 06:15 AMLLY+1.31%ELIS0.00%
J&J Says TECVAYLI+TALVEY Cuts Risk Of Disease Progression Or Death By 89% In Multiple Myeloma Trialrttnews·1 day ago, 08:09 AMJNJ+1.42%
Johnson & Johnson posts press release on MonumenTAL-6 multiple myeloma trial resultsPUBT·1 day ago, 07:30 AMJNJ+1.42%
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trialsCNBC·1 day ago, 05:45 AMLLY+1.31%ELIS0.00%
Public Employees Retirement System of Ohio Has $125.54 Million Stock Position in Merck & Co., Inc. $MRKMarket Beat·6 hours agoMRK+0.56%
HBM Healthcare swings to CHF 238 million Q1 FY27 profit; NAV per share rises 13%PUBT·12 hours agoLLY+1.31%ELIS0.00%
Johnson & Johnson's Ottava gets FDA approval; Goldman launches private-company investing platformCoinLive·1 day ago, 02:05 PMJNJ+1.42%GS-D+0.42%
Agilent wins EU approval for PD-L1 IHC 22C3 test in ovarian cancer patientsPUBT·1 day ago, 07:04 AMA-0.65%MRK+0.56%
Johnson & Johnson wins FDA De Novo clearance for OTTAVA robotic surgery system in USPUBT·2 days ago, 06:04 AMJNJ+1.42%
